Lichtenfeld: “I See a 4,150% Earnings Setup in This $6 Biotech”

By Travis Johnson, Stock Gumshoe, April 13, 2015

This article originally ran on January 12… the teaser pitch was still being circulated heavily last week, and the stock released earnings on February 3 that disappointed investors, bringing shares down about 15% (it was teased as a “$7 biotech,” and briefly $8, before then).

The original Jan. 14 “special event” catalyst teased by Lichtenfeld, their presentation at the JP Morgan healthcare conference, had no real impact on the stock at all. The ads still say it’s a current catalyst, though that conference is four months past — so it’s likely they didn’t revamp the ad much, it’s just catching more investor eyes at the moment (and driving more questions our way).

Other than that, we have not looked at the pitch other than to confirm that the “meat” of the argument and the stock pick are unchanged. What follows is unchanged from 1/12/15.

I thought I’d take a quick look at this one today, though a couple Irregulars have already identif